Ranbaxy

Showing 15 posts of 45 posts found.

Ranbaxy picture

Ranbaxy taken to task by FDA over manufacturing woes

January 31, 2012
Manufacturing and Production FDA, Ranbaxy, manufacturing, woes

Indian pharma company Ranbaxy will be banned from manufacturing drugs at certain plants for the US market until it corrects …

Teva picture

Teva gains tentative approval to sell generic Lipitor in 2012

December 5, 2011
Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva

Teva has gained a tentative approval by the FDA to sell its generic form of Pfizer’s blockbuster statin Lipitor next …

FDA approves Ranbaxy’s generic Lipitor

December 1, 2011
Manufacturing and Production, Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva

The FDA will allow Ranbaxy to develop a generic version of Pfizer’s blockbuster statin Lipitor. The firm has received final …

The changing of the guard – Q3 round up

November 25, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lipitor, Q3, Ranbaxy

 PfizerOf all the patent cliffs in pharma, Lipitor’s expiry represents the biggest. Pfizer is now staring over the precipice, with …

Ranbayx image

Ranbaxy to collaborate with Teva on generic Lipitor in US?

November 7, 2011
Manufacturing and Production, Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva

Israeli drugmaker Teva Pharmaceutical could get an unexpected boost from an earlier-than-expected launch of its generic version of Pfizer’s cholesterol …

AZ’s Nexium faces generic competition in the UK

September 6, 2011
Nexium, Ranbaxy, generics

Generic specialist Ranbaxy has launched its version of AstraZeneca’s anti-ulcer blockbuster Nexium in the UK. It will be available in …

Ranbaxy closes down troubled liquid formulations plant

August 12, 2011
Manufacturing and Production FDA, Ranbaxy, pharma manufacturing news, quality control

Indian drugmaker Ranbaxy Laboratories has decided to close down a manufacturing facility in the USA which has been under scrutiny …

Pharma manufacturing news in brief

September 7, 2010
Manufacturing and Production Aegis Protek, Alexion, Halozyme, Ranbaxy, SemBioSys

A round-up of pharma manufacturing developments from Ranbaxy, SemBioSys, Halozyme, Aegis Protek, Alexion and Thomson/Rondaxe. Ranbaxy Laboratories of India has …

ArunSawhneyWebV

Ranbaxy chief executive steps down

August 13, 2010
Medical Communications, Sales and Marketing Daiichi Sankyo, Ranbaxy

The chief executive of Ranbaxy Mr Atul Sobti is to step down after an apparent a rift with the company’s …

Pharma manufacturing news in brief

May 24, 2010
Manufacturing and Production Angel Biotech, Halozyme, Johnson Matthey, Ranbaxy, Sagent Pharmaceuticals, baxter

There are more quality problems to report on the manufacturing beat this week, with recalls for Ranbaxy, Halozyme/Baxter and Sagent …

Ranbaxy woes revealed in FDA warning letter

February 9, 2010
Manufacturing and Production Ranbaxy

Ranbaxy has not taken adequate measures to correct deficiencies at its manufacturing plants, according to a communication from the US …

Ranbaxy scales back manufacturing presence in China

January 7, 2010
Manufacturing and Production China, Guangzhou Baiyunshan Pharmaceutical Company, HNG Chembio Pharmacy, Hong Kong New Chemic, Ranbaxy

Ranbaxy has shaken up its operations in China with the divestment of its stake a joint venture with Guangzhou Baiyunshan …

Pharma manufacturing news in brief

January 7, 2010
Manufacturing and Production Acino, AlphaRx, DSM BioSolutions, Enzon, Indoco Remedies, Jubilant Organosys, Mayoly Spindler, NYK Logistics, Ranbaxy, Venturepharm Laboratories

Our round-up of developments in manufacturing includes contracts for DSM and Venturepharm, facility updates from Indoco and Jubilant, and an …

Ranbaxy woes continue with antibiotic recall

May 6, 2009
Sales and Marketing Ranbaxy, US

Indian drugmaker Ranbaxy Laboratories has recalled an antibiotic on sale in the US, suggesting that it still has some way …

FDA puts block on Ranbaxy products

March 4, 2009
Manufacturing and Production Ranbaxy

India’s Ranbaxy Laboratories has been dealt another blow by the FDA after the agency suspended regulatory review of any products …

The Gateway to Local Adoption Series

Latest content